BioNTech SE (BNTX)
110.14
-0.28
(-0.25%)
USD |
NASDAQ |
Feb 20, 16:00
110.29
+0.14
(+0.13%)
After-Hours: 20:00
BioNTech Profit Margin (Quarterly) : -1.89% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CureVac NV | -- |
| Merck & Co., Inc. | 18.06% |
| Novavax, Inc. | -287.3% |
| Pfizer Inc. | -9.34% |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.00% |
| Return on Assets | -2.60% |
| Return on Invested Capital | -2.96% |
| Gross Profit Margin (Quarterly) | 90.24% |
| Operating Margin (Quarterly) | 41.89% |
| Return on Net Operating Assets | -13.62% |